1. Home
  2. DGII vs COLL Comparison

DGII vs COLL Comparison

Compare DGII & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Digi International Inc.

DGII

Digi International Inc.

N/A

Current Price

$49.61

Market Cap

1.7B

Sector

Technology

ML Signal

N/A

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

N/A

Current Price

$37.30

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DGII
COLL
Founded
1985
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
DGII
COLL
Price
$49.61
$37.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$48.80
$50.83
AVG Volume (30 Days)
277.4K
387.1K
Earning Date
05-06-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
77.05
N/A
EPS
0.31
1.73
Revenue
$430,221,000.00
$780,567,000.00
Revenue This Year
$18.71
$6.07
Revenue Next Year
$7.22
N/A
P/E Ratio
$157.31
$21.55
Revenue Growth
1.46
23.62
52 Week Low
$22.39
$23.23
52 Week High
$51.78
$50.79

Technical Indicators

Market Signals
Indicator
DGII
COLL
Relative Strength Index (RSI) 56.47 21.42
Support Level $47.00 $34.30
Resistance Level $51.78 $39.85
Average True Range (ATR) 1.96 1.59
MACD -0.13 -0.80
Stochastic Oscillator 57.38 10.14

Price Performance

Historical Comparison
DGII
COLL

About DGII Digi International Inc.

Digi International Inc is a Minnesota corporation that provides business and mission-critical Internet of Things (IoT) connectivity products and services. It operates through two segments: IoT Products & Services, which supports OEMs, enterprise, and government customers in deploying secure IoT connectivity solutions, and IoT Solutions, consisting of SmartSense and its Managed Network-as-a-Service (MNaaS) business offering wireless temperature and condition-based monitoring, employee task management, label printing, and other services. The company generates the majority of its revenue from the IoT Products & Services segment and mainly from the United States, with a presence in Europe, the Middle East and Africa, and the Rest of the world.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: